BelHealth Investment Partners, a healthcare-focused private equity firm, announced that Bryce Miller and Cameron Weiner have joined as Associates. Mr. Miller will be a member of the investment team and Mr. Weiner will focus solely on business development and origination.
Mr. Miller’s responsibilities will range from deal origination to due diligence, execution and portfolio company monitoring. Prior to joining BelHealth, he served as an Investment Banking Analyst at Stephens Inc. where he focused primarily on healthcare transactions. During his time at Stephens, he worked in both New York and Little Rock. Mr. Miller received a Masters in Finance from Vanderbilt University and a Bachelor of Science from Centre College.
Mr. Weiner will focus exclusively on bolstering BelHealth’s origination and sourcing capabilities. He will support these efforts and assist in strengthening relationships with the firm’s network of business brokers and strategic partners. Prior to joining BelHealth, Mr. Weiner spent three years at General Electric, where he completed GE Capital’s Leadership Development Program and then spent a year on the Global Business Development team as an M&A Associate. Mr. Weiner received a Bachelor of Arts from the University of North Carolina at Chapel Hill.
Nathan Kronforst, Managing Director of BelHealth, said, “We are excited to welcome Bryce and Cameron to the team as BelHealth continues to grow. Bryce brings a strong analytical skillset to fortify our investment team as we continue to support our existing portfolio companies and partner with new entrepreneurs. Furthermore, Cameron enhances our deal sourcing capabilities, a crucial part of our disciplined investment approach.”
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes will benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.
